China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly Asset Utilization Ratio came in at 0.1 in Q1 2026, down 64.48% YoY from 0.3 in Q1 2025, and down 40.8% on a QoQ basis from 0.18 in Q4 2025.
China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 16 years of Asset Utilization Ratio data on file, last reported at 0.1 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 64.48% year-over-year to 0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.1 (down 64.48% YoY) and the FY2025 annual result came in at 0.18, down 37.47% from the prior year.
- Asset Utilization Ratio slipped to 0.1 in Q1 2026, from 0.18 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.5 in Q3 2023 to a low of 0.1 in Q1 2026.
- A 5-year average of 0.37 and a median of 0.41 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio grew 18.36% — and 2026, when it tumbled 64.48%.
- Tracing CPHI's Asset Utilization Ratio over 5 years: stood at 0.48 in 2022, then fell by 7.6% to 0.44 in 2023, then declined by 27.5% to 0.32 in 2024, then plunged by 44.57% to 0.18 in 2025, then slumped by 40.8% to 0.1 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.1 (Q1 2026), 0.18 (Q4 2025), and 0.27 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.31 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.47 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.51 |
| Jun 30, 2021 | 0.51 |